• Study on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark France Germany Greece +5
  • Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Czechia Denmark Germany Hungary Italy The Netherlands +2
  • Study Comparing OXU-001 and Intravitreal Dexamethasone for Patients with Diabetic Macular Edema

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Hungary Spain
  • Study of Atezolizumab and RP1 for Patients with Early-Stage Triple-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Danicamtiv for Patients with Primary Dilated Cardiomyopathy Due to MYH7 or TTN Gene Variants

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Spain
  • Study of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Breast Cancer Resistant to Trastuzumab, Pertuzumab, and Taxane Treatment

    Not recruiting

    2 1 1
    Investigated drugs:
    Spain
  • Study on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Italy The Netherlands +2
  • Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis

    Not recruiting

    2 1 1
    Austria Belgium Czechia France Hungary Italy +2
  • Study of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Hungary Italy The Netherlands Norway +2
  • Study of Retatrutide for Patients with Type 2 Diabetes and Obesity or Overweight

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Romania Spain

powered by